Acute granulocytic leukemia: treatment of the disease.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000628:therapy; D008130:Lomustine / Q000627:therapeutic use; D008581:Meningitis / Q000150:complications; D008875:Middle Aged; D011379:Prognosis; D013866:Thioguanine / Q000627:therapeutic use
D003561:Cytarabine; D008130:Lomustine; D003520:Cyclophosphamide; D013866:Thioguanine; D003630:Daunorubicin